Tcg Crossover Management, LLC Fulcrum Therapeutics, Inc. Call Options Transaction History
Tcg Crossover Management, LLC
- $771 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FULC
# of Institutions
138Shares Held
53.9MCall Options Held
4.17MPut Options Held
515K-
Ra Capital Management, L.P. Boston, MA10.2MShares$36.4 Million0.51% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$17.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$17 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$11.7 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$8.34 Million5.16% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $185M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...